Trials
Search / Trial NCT05647538

Bilateral Uterine Artery Ligation After Intrapartum or Postpartum Hemorrhage on Ovarian Reserve Markers and Pregnancy Outcome

Launched by TANTA UNIVERSITY · Dec 4, 2022

Trial Information

Current as of January 14, 2025

Completed

Keywords

ClinConnect Summary

One of the most common surgical methods for preserving fertility is uterine artery ligation. It is simple to do and effective at reducing Postpartum hemorrhage after delivery . Additionally, it is rather safe and permits future childbearing for the patients.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 120 females aged from 20 to 35 years old
  • with Postpartum hemorrhage or intrapartum hemorrhage after cesarean section
  • did not respond to medical therapy
  • performed successful bilateral uterine artery ligation for hemorrhage management.
  • Exclusion Criteria:
  • The presence of male factor or tubal factor.
  • Hypertension, autoimmune disease, morbid obesity, absence of lactation diabetes millets, vascular disease, smoking or the use of alcohol.
  • The presence of additional surgery or medical disease.
  • Detection of a uterine anomaly, history of intrauterine growth restriction in previous pregnancies.
  • Usage of a hormonal therapy through the research.

About Tanta University

Tanta University is a prestigious academic institution located in Egypt, dedicated to advancing medical research and education. As a clinical trial sponsor, Tanta University leverages its extensive resources and expertise to conduct innovative research initiatives aimed at improving health outcomes. The university collaborates with a network of healthcare professionals, researchers, and institutions to facilitate rigorous clinical trials across various medical disciplines. Committed to ethical standards and scientific integrity, Tanta University strives to contribute to the global body of knowledge while fostering the next generation of medical professionals.

Locations

Tanta, , Egypt

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials